Study #2014-0213
Varenicline and Combined NRT for Initial Smoking Cessation and Rescue Treatment in Smokers: A Randomized Pilot Trial
MD Anderson Study Status
Not Accepting
Treatment Agent
Varenicline, Nicotine Lozenge, Nicotine Patch
Description
This randomized pilot phase IV trial studies the side effects and how well varenicline works compared to nicotine replacement therapy in helping patients that smoke to quit. Varenicline is a drug that acts the same way as nicotine in the brain but is not habit-forming. Nicotine replacement therapy consists of nicotine patches and lozenges. It is not yet known if varenicline is more effective than nicotine replacement therapy in helping patients quit smoking.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cigarette Smoker, Tobacco Use Disorder
Study phase:
Phase IV
Physician name:
Jason Robinson
Department:
Behavioral Science
For general questions about clinical trials:
1-855-493-3260
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.